Invacare Corporation

OTCPK:IVCR.Q Voorraadrapport

Marktkapitalisatie: US$512.8k

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Invacare Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Invacare's earnings have been declining at an average annual rate of -2.6%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 4.5% per year.

Belangrijke informatie

-2.6%

Groei van de winst

-0.2%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie8.9%
Inkomstengroei-4.5%
Rendement op eigen vermogen-124.6%
Nettomarge-13.6%
Laatste winstupdate31 Dec 2022

Recente prestatie-updates uit het verleden

Recent updates

Invacare falls on bankruptcy filing

Feb 01

Invacare announces additional draw of $5.5M term loans

Dec 27

Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates

Nov 14
Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates

Invacare GAAP EPS of -$0.92, revenue of $170.4M

Nov 07

Invacare receives non-compliance letter from NYSE

Sep 29

Invacare names Geoffrey Purtill as interim president and executive chief

Aug 29

Invacare adds two new directors after deal with largest investor Azurite

Aug 23

Returns Are Gaining Momentum At Invacare (NYSE:IVC)

Apr 30
Returns Are Gaining Momentum At Invacare (NYSE:IVC)

Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky

Jan 27
Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

Dec 01
Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load

Sep 30
Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load

When Should You Buy Invacare Corporation (NYSE:IVC)?

Aug 06
When Should You Buy Invacare Corporation (NYSE:IVC)?

Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)

May 14
Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)

Invacare EPS misses by $0.02, misses on revenue

May 05

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

May 03
Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

Invacare Corporation's (NYSE:IVC) Path To Profitability

Mar 03
Invacare Corporation's (NYSE:IVC) Path To Profitability

Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet

Feb 05
Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet

What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?

Jan 10
What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?

Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.

Dec 14
Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.

Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit

Nov 23
Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit

Invacare Corporation 2020 Q3 - Results - Earnings Call Presentation

Oct 30

Opbrengsten en kosten

Hoe Invacare geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

OTCPK:IVCR.Q Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
31 Dec 22742-1012280
30 Sep 22787-792250
30 Jun 22840-672230
31 Mar 22877-562320
31 Dec 21872-462310
30 Sep 21870-532410
30 Jun 21858-372400
31 Mar 21828-432340
31 Dec 20851-282370
30 Sep 20860-422360
30 Jun 20883-432460
31 Mar 20923-392560
31 Dec 19928-532600
30 Sep 19940-362640
30 Jun 19948-402700
31 Mar 19959-442760
31 Dec 18972-442820
30 Sep 18978-602880
30 Jun 18984-672940
31 Mar 18972-742950
31 Dec 17966-772970
30 Sep 17963-772990
30 Jun 17980-633010
31 Mar 171,022-513040
31 Dec 161,047-433040
30 Sep 161,084-283030
30 Jun 161,100-313030

Kwaliteitswinsten: IVCR.Q is currently unprofitable.

Groeiende winstmarge: IVCR.Q is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: IVCR.Q is unprofitable, and losses have increased over the past 5 years at a rate of 2.6% per year.

Versnelling van de groei: Unable to compare IVCR.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: IVCR.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).


Rendement op eigen vermogen

Hoge ROE: IVCR.Q has a negative Return on Equity (-124.64%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden